glp 1 agonist or antagonist GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes Exploring the Side Effects of
Description
doi: 10.18502/ijph.v50i12.7926
Introduction The obesity and metabolic disease epidemic continues to surge, with over 40% of U.S
After administration of Triple GLP-1/GIP/glucagon receptor agonist, learning and memory impairment of AD models (APP/PS1 mice and 3Tg-AD mice) was improved, amyloid plaques, tau pathology, inflammation response and oxidative stress in brains of two AD models were ameliorated (239241)
Competing interests J.O
Lets focus on improving our own health literacy so we can feel better, function better, and live longer.
[DOI] [PubMed] [Google Scholar] 97.Pratley R, Amod A, Hoff ST, et al
